Friday, July 10, 2026

Drug profile · INN

iodamide meglumine

iodamide meglumine (RENOVUE-DIP) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — iodamide meglumine
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

iodamide meglumine (RENOVUE-DIP) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN iodamide meglumine
Brand RENOVUE-DIP
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is iodamide meglumine?

iodamide meglumine (RENOVUE-DIP) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for iodamide meglumine?

RENOVUE-DIP is a marketed brand name for iodamide meglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of iodamide meglumine?

iodamide meglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.